SHREE GANESH REMEDIES
Back to Income Statement
|
SHREE GANESH REMEDIES Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2020 | Mar2019 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹18 Cr | ₹23 Cr | ₹28 Cr | ₹10 Cr | ₹6.24 Cr |
What is the latest Consolidated Net Profit of SHREE GANESH REMEDIES ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹18 Cr |
| Mar2025 | ₹23 Cr |
| Mar2024 | ₹28 Cr |
| Mar2020 | ₹10 Cr |
| Mar2019 | ₹6.24 Cr |
How is Consolidated Net Profit of SHREE GANESH REMEDIES Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹18 Cr | -23.01 | |
| Mar2025 | ₹23 Cr | -17.93 | |
| Mar2024 | ₹28 Cr | 168.44 | |
| Mar2020 | ₹10 Cr | 67.94 | |
| Mar2019 | ₹6.24 Cr | - | |
Compare Consolidated Net Profit of peers of SHREE GANESH REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHREE GANESH REMEDIES | ₹887.3 Cr | 3.1% | 1.3% | 29.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹434,280.0 Cr | -2.4% | -6.2% | 11.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,737.0 Cr | -3.3% | 1.4% | 57.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,129.0 Cr | -4.5% | -4% | 35.9% | Stock Analytics | |
| CIPLA | ₹108,808.0 Cr | -3.6% | -5% | -10.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,170.0 Cr | -0.2% | 2.5% | -3% | Stock Analytics | |
SHREE GANESH REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHREE GANESH REMEDIES | 3.1% |
1.3% |
29.7% |
| SENSEX | -2.3% |
-6.6% |
-12% |
You may also like the below Video Courses